Abstract:Chenrui Zhang, 1 Jinping Li, 2 Rong Lu, 2 Song Wang, 2 Zheng Fu, 2 Zhi Yao 1 1 Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China; 2 Kangzhe Pharmaceutical Technology Development Company, Ltd., Tianjin, People's Republic of China Correspondence: Zhi Yao, Tianjin Medical University, Tianjin, 300070, People's Republic of China, Tel/Fax +8622-83336817, Email Zheng Fu, Kangzhe Pharmaceutical Technology Development Company, Tianjin, 300110, People's Republic of China, Tel/Fax +86 13821232027, Email Background: The number of incidences of antimicrobial resistance is rising continually, necessitating new and effective antibacterial drugs. The present study aimed to assess the in vitro and in vivo activity of XF-73 against antibiotic-resistant Staphylococcus aureus ( S. aureus ) isolates and to investigate the potential mechanism of action of XF-73. Methods: The in vitro antibacterial activity of XF-73 and comparator antibacterial drugs, (mupirocin, fusidine, retapamulin, vancomycin, erythromycin, linezolid and daptomycin), against S. aureus (both antibiotic sensitive and resistant strains) was assessed using a broth microdilution method. Two different superficial Staphylococcal skin infection murine models were established to study the in vivo efficacy of XF-73 against antibiotic-resistant strains. The effect of XF-73 on the ultrastructure and cellular morphology of S. aureus was studied using transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Results: The MICs (minimum inhibitory concentration) determined by the broth microdilution method for XF-73 demonstrated that the compound had a high potency against S. aureus isolates with varying susceptibility to the study drugs. Also, the antibacterial activity of XF-73 was superior or similar to most of the tested antibacterial drugs. We also found that the XF-73 dermal formulation significantly inhibited S. aureus survival in both the murine skin tape-stripping and suture superficial skin infection models, maintained a consistently high inhibitory capacity against the antibiotic-resistant strains tested and was significantly more effective than mupirocin ointment, a commonly used antibiotic for the treatment of skin infections. The morphological studies using TEM suggest that XF-73 had a rapid (2 minute) bacterial cell wall disruption activity, with longer incubation (10 minute) subsequently causing membrane damage. SEM analysis demonstrated that this cell wall and cell membrane disruption did not lead to disintegration of the plasma membrane, and did not cause bacterial cell lysis. Conclusion: Therefore, XF-73 may be an effective drug alternative to combat multi-drug-resistant skin infections in the clinical setting. Keywords: antibiotic resistance, mupirocin-resistant strains, skin infections, bacterial cell membrane, in vivo, S. aureus Skin and soft tissue infections (SSTIs) are some of the most common bacterial infections. Many bacteria and fungi species reside on the surface of human skin which are usually prevented from entering the body by the intact skin barrier and do not pose a threat of infection. However, in the case of skin damage, bacteria may invade the skin and subcutaneous tissue to cause infection. SSTIs are mainly caused by Gram-positive bacteria, especially S. aureus . In addition, SSTIs are clinical conditions that vary in severity, etiology, and presentation. They include microbial invasion of the skin and underlying soft tissues and range in severity from relatively minor to extremely serious, ie, fatal infections. 1 Infections limited to the skin and underlying superficial soft tissue are termed simple infections; for example, cellulitis, impetigo, and trauma-associated infections. A simple infection is characterized by the absence of systemic symptoms that indicate the spread of infection and the absence of complications that could make treatment challenging. For simple infections, topical antimicrobials, such as the topical antibiotics mupirocin and fusidic acid, are optimal. 2 In vitro studies have demonstrated that mupirocin exhibits good antimicrobial activity against Gram-positive cocci such as S. aureus, Staphylococcus epidermidis , and other β-hemolytic streptococci , 3 which are the most common pathogens associated with primary and secondary skin infections. Mupirocin (2% w/w) is a marketed ointment (Bactroban ® ). Clinical trials have demonstrated th -Abstract Truncated-

Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study

A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation

Efficacy and Safety of Xylitol Nasal Irrigation after Functional Endoscopic Sinus Surgery: A Randomized Controlled Study

Alcohol-based Nasal Decolonization and Chlorhexidine Bathing to Reduce Methicillin-resistant Staphylococcus Aureus Hospital-acquired Infections in Critical Patients

Staphylococcus aureus screening and preoperative decolonisation with Mupirocin and Chlorhexidine to reduce the risk of surgical site infections in orthopaedic surgery: a pre-post study

Nasal decolonization: What antimicrobials and antiseptics are most effective before surgery and in the ICU

Effect of recombinant human acidic fibroblast growth factor on nasal mucosal healing after endoscopic sinus surgery

Nasal microbiome and the effect of nasal decolonization with a novel povidone-iodine antiseptic solution: a prospective and randomized clinical trial

Pre-operative administration of butorphanol mitigates emergence agitation in patients undergoing functional endoscopic sinus surgery: A randomized controlled clinical trial

Efficacy of a Novel Antibacterial Agent Exeporfinium Chloride, (XF-73), Against Antibiotic-Resistant Bacteria in Mouse Superficial Skin Infection Models

Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty

Determination of the effect of topical application of N-acetylcysteine on the recovery rate of patients with chronic rhinosinusitis after surgical treatment, based on SNOT-22 test scores

Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)

Successful prophylactic measures for the eradication of Staphylococcus aureus infections in elective hip primary and revision arthroplasty

[Sorbalgon Strips for Nasal Packing Used in 2013 Cases of Endoscopic Sinus Surgery].

Mupirocin Ointment Effect on Polyposis Recurrence After Sinus Surgery

Effectiveness of Preoperative Antiseptic Preparation in Transnasal Skull Base Surgery: A Randomized Three-Arm Controlled Trial

Single-blind randomized controlled trial of surfactant vs hypertonic saline irrigation following endoscopic endonasal surgery

Efficacy of Clarithromycin Combined with Fluticasone Propionate on Nasal Function, Nasal Mucociliary Transport Function, and Serum Inflammatory Markers in Chronic Rhinosinusitis Patients After Functional Endoscopic Sinus Surgery

1199. Implementation of a Nasal Antiseptic Decolonization Program Reduces the Occurrence of Healthcare-Associated Infections in the Adult Intensive Care Unit Setting

The efficacy of a nitric oxide-releasing formulation on nares isolated Methicillin-Resistant Staphylococcus aureus in porcine wound infection model